Nymirum
Base4 focuses on rna-targeted therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD3—5m (Dealroom.co estimates May 2009.)
Ann Arbor Michigan (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$550k | Seed | ||
$2.8m | Grant | ||
Total Funding | AUD5.2m |
Recent News about Nymirum
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.